GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹1,635 Cr | ₹2,320 Cr | ₹2,084 Cr | ₹1,698 Cr | ₹1,586 Cr |
What is the latest Operating Profit of GLENMARK PHARMACEUTICALS ?
Year | Operating Profit |
---|---|
Mar2024 | ₹1,635 Cr |
Mar2023 | ₹2,320 Cr |
Mar2022 | ₹2,084 Cr |
Mar2021 | ₹1,698 Cr |
Mar2020 | ₹1,586 Cr |
How is Operating Profit of GLENMARK PHARMACEUTICALS Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,635 Cr | -29.53 | |
Mar2023 | ₹2,320 Cr | 11.32 | |
Mar2022 | ₹2,084 Cr | 22.75 | |
Mar2021 | ₹1,698 Cr | 7.08 | |
Mar2020 | ₹1,586 Cr | - |
Compare Operating Profit of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹62,734.5 Cr | 2.1% | 34.1% | 56.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 2.1% |
34.1% |
56.5% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses